Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols including natural products
Özet
(2-Bromo-3,4-dimethoxyphenyl) (3,4-dimethoxyphenyl)methanone (10) and its derivatives with Br, one dibromide and isomeric three tribromides, were synthesized. Demethylation of these compounds afforded a series of new bromophenols. Inhibition of human cytosolic carbonic anhydrase II (hCA II) isozyme by these new bromophenols and naturally occurring 3,4,6-tribromo-5-(2,5- dibromo-3,4-dihydroxybenzyl)benzene-1,2-diol (3), and 5,5′-methylenebis(3, 4,6-tribromo-benzene-1,2-diol) (4) was investigated. The synthesized compounds showed carbonic anhydrase inhibitory capacities with IC 50 values in the range of 0.7372 μM against hCA II. Some bromophenols investigated here showed effective hCA II inhibitory activity and might be used as leads for generating novel carbonic anhydrase inhibitors which are valuable drug candidates for the treatment of glaucoma, epilepsy, gastric and duodenal ulcers, neurological disorders, or osteoporosis.
Anahtar Kelimeler
- Scopus
- 42
- WoS
- 43
- OpenAlex
- 41
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Balaydiin, Halis Türker | |
| dc.contributor.author | Soyut, Hakan | |
| dc.contributor.author | Ekinci, Deniz | |
| dc.contributor.author | Göksu, Sleyman | |
| dc.contributor.author | Beydemir, Şkrü | |
| dc.contributor.author | Menzek, Abdullah | |
| dc.contributor.author | Şahin, Ertan | |
| dc.date.accessioned | 2026-10-29T19:11:43.325934213Z | |
| dc.date.available | 2026-10-29T19:11:43.325934213Z | |
| dc.date.issued | 2012 | |
| dc.description.abstract | (2-Bromo-3,4-dimethoxyphenyl) (3,4-dimethoxyphenyl)methanone (10) and its derivatives with Br, one dibromide and isomeric three tribromides, were synthesized. Demethylation of these compounds afforded a series of new bromophenols. Inhibition of human cytosolic carbonic anhydrase II (hCA II) isozyme by these new bromophenols and naturally occurring 3,4,6-tribromo-5-(2,5- dibromo-3,4-dihydroxybenzyl)benzene-1,2-diol (3), and 5,5′-methylenebis(3, 4,6-tribromo-benzene-1,2-diol) (4) was investigated. The synthesized compounds showed carbonic anhydrase inhibitory capacities with IC 50 values in the range of 0.7372 μM against hCA II. Some bromophenols investigated here showed effective hCA II inhibitory activity and might be used as leads for generating novel carbonic anhydrase inhibitors which are valuable drug candidates for the treatment of glaucoma, epilepsy, gastric and duodenal ulcers, neurological disorders, or osteoporosis. | |
| dc.description.sponsorship | TÜBİTAK | |
| dc.description.sponsorship | Türkiye Bilimsel ve Teknolojik Araştirma Kurumu, TÜBITAK, (TBAG-107T348) | |
| dc.description.sponsorship | Türkiye Bilimsel ve Teknolojik Araştirma Kurumu, TÜBITAK | |
| dc.identifier.doi | 10.3109/14756366.2011.574131 | |
| dc.identifier.eissn | 1475-6374 | |
| dc.identifier.endpage | 50 | |
| dc.identifier.issn | 1475-6374 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmid | 21635211 | |
| dc.identifier.scopus | 2-s2.0-79959914230 | |
| dc.identifier.startpage | 43 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/bayburt/13975 | |
| dc.identifier.volume | 27 | |
| dc.identifier.wos | WOS:000298748800008 | |
| dc.language.iso | en | |
| dc.publisher | TAYLOR & FRANCIS LTD | |
| dc.relation.ispartof | Journal of Enzyme Inhibition and Medicinal Chemistry | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Bromophenols | |
| dc.subject | Carbonic anhydrase | |
| dc.subject | Diphenylmethane | |
| dc.subject | Enzyme inhibition | |
| dc.subject | Glaucoma | |
| dc.subject.classification | Biochemistry & Molecular Biology | |
| dc.subject.classification | Chemistry, Medicinal | |
| dc.subject.classification | Pharmacology & Pharmacy | |
| dc.subject.other | Benzophenones | |
| dc.subject.other | Biological Agents | |
| dc.subject.other | Bromobenzenes | |
| dc.subject.other | Carbonic Anhydrase II | |
| dc.subject.other | Carbonic Anhydrase Inhibitors | |
| dc.subject.other | Catechols | |
| dc.subject.other | Cytosol | |
| dc.subject.other | Dose-Response Relationship, Drug | |
| dc.subject.other | Humans | |
| dc.subject.other | Isoenzymes | |
| dc.subject.other | Molecular Structure | |
| dc.subject.other | Stereoisomerism | |
| dc.subject.other | Structure-Activity Relationship | |
| dc.subject.other | (2 bromo 3,4 dihydroxyphenyl)(2 bromo 4,5 dihydroxyphenyl)methanone | |
| dc.subject.other | (2 bromo 3,4 dihydroxyphenyl)(2,3 dibromo 4,5 dihydroxyphenyl)methanone | |
| dc.subject.other | (2 bromo 3,4 dimethoxyphenyl)(2 bromo 4,5 dimethoxyphenyl)methanone | |
| dc.subject.other | (2 bromo 3,4 dimethoxyphenyl)(2,3 dibromo 4,5 dimethoxyphenyl)methanone | |
| dc.subject.other | (2 bromo 3,4 dimethoxyphenyl)(3,4 dimethoxyphenyl)methanone | |
| dc.subject.other | (2 bromo 4,5 dihydroxyphenyl)(2,5 dibromo 3,4 dihydroxyphenyl)methanone | |
| dc.subject.other | (2 bromo 4,5 dihydroxyphenyl)(2,6 dibromo 3,4 dimethoxyphenyl)methanone | |
| dc.subject.other | (2 bromo 4,5 dimethoxyphenyl)(2,5 dibromo 3,4 dimethoxyphenyl)methanone | |
| dc.subject.other | (2 bromo 4,5 dimethoxyphenyl)(2,6 dibromo 3,4 dimethoxyphenyl)methanone | |
| dc.subject.other | 3,4,6 tribromo 5 (2,5 dibromo 3,4 dihydroxybenzyl)benzene 1,2 diol | |
| dc.subject.other | 5,5' methylene bis(3,4,6 tribromo benzene 1,2 diol) | |
| dc.subject.other | bromine derivative | |
| dc.subject.other | bromophenol blue | |
| dc.subject.other | carbonate dehydratase II | |
| dc.subject.other | carbonate dehydratase inhibitor | |
| dc.subject.other | unclassified drug | |
| dc.subject.other | article | |
| dc.subject.other | bromination | |
| dc.subject.other | demethylation | |
| dc.subject.other | drug synthesis | |
| dc.subject.other | enzyme inhibition | |
| dc.subject.other | human | |
| dc.subject.other | IC 50 | |
| dc.subject.other | priority journal | |
| dc.title | Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols including natural products | |
| dc.type | Article | |
| rdl.citation.openalex | 41 | |
| rdl.citation.scopus | 42 | |
| rdl.citation.wos | 43 | |
| rdl.oa.status | bronze | |
| rdl.oa.url | https://www.tandfonline.com/doi/pdf/10.3109/14756366.2011.574131?needAccess=true | |
| rdl.scopus.quartile | Q2 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

